亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

体内 多重耐药 药理学 克拉斯 体外 医学 生物 癌症研究 抗药性 癌症 内科学 遗传学 结直肠癌
作者
Yuchen Zhang,Cheukfai Li,Chenglai Xia,Keneth Kin Wah To,Zhixing Guo,Chongyang Ren,Lingzhu Wen,Fang Wang,Liwu Fu,Ning Liao
出处
期刊:Cell Communication and Signaling [BioMed Central]
卷期号:20 (1): 142-142 被引量:33
标识
DOI:10.1186/s12964-022-00955-8
摘要

Abstract Background Multidrug resistance (MDR) is a complex phenomenon that frequently leads to chemotherapy failure during cancer treatment. The overexpression of ATP-binding cassette (ABC) transporters represents the major mechanism contributing to MDR. To date, no effective MDR modulator has been applied in clinic. Adagrasib (MRTX849), a specific inhibitor targeting KRAS G12C mutant, is currently under investigation in clinical trials for the treatment of non-small cell lung cancer (NSCLC). This study focused on investigating the circumvention of MDR by MRTX849. Methods The cytotoxicity and MDR reversal effect of MRTX849 were assessed by MTT assay. Drug accumulation and drug efflux were evaluated by flow cytometry. The MDR reversal by MRTX849 in vivo was investigated in two ABCB1-overexpressing tumor xenograft models in nude mice. The interaction between MRTX849 and ABCB1 substrate binding sites was studied by the [125I]-IAAP-photoaffinity labeling assay. The vanadate-sensitive ATPase assay was performed to identify whether MRTX849 would change ABCB1 ATPase activity. The effect of MRTX849 on expression of ABCB1 and PI3K/AKT signaling molecules was examined by flow cytometry, Western blot and Quantitative Real-time PCR analyses. Results MRTX849 was shown to enhance the anticancer efficacy of ABCB1 substrate drugs in the transporter-overexpressing cells both in vitro and in vivo. The MDR reversal effect was specific against ABCB1 because no similar effect was observed in the parental sensitive cells or in ABCG2-mediated MDR cells. Mechanistically, MRTX849 increased the cellular accumulation of ABCB1 substrates including doxorubicin (Dox) and rhodamine 123 (Rho123) in ABCB1-overexpressing MDR cells by suppressing ABCB1 efflux activity. Additionally, MRTX849 stimulated ABCB1 ATPase activity and competed with [125I]-IAAP for photolabeling of ABCB1 in a concentration-dependent manner. However, MRTX849 did not alter ABCB1 expression or phosphorylation of AKT/ERK at the effective MDR reversal drug concentrations. Conclusions In summary, MRTX849 was found to overcome ABCB1-mediated MDR both in vitro and in vivo by specifically attenuating ABCB1 efflux activity in drug-resistant cancer cells. Further studies are warranted to translate the combination of MRTX849 and conventional chemotherapy to clinical application for circumvention of MDR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
YuxinChen完成签到 ,获得积分10
7秒前
快乐的稚晴完成签到,获得积分10
13秒前
25秒前
小蘑菇的应助被科研通管家采纳,获得10
25秒前
51秒前
闪闪雍完成签到,获得积分10
52秒前
1分钟前
健忘的小萱完成签到,获得积分10
1分钟前
玩命的芸遥完成签到,获得积分10
1分钟前
Andrew发布了新的文献求助10
1分钟前
Andrew完成签到,获得积分10
1分钟前
1分钟前
1分钟前
wanci的应助被五岁的哈士奇采纳,获得10
1分钟前
魔幻雪兰完成签到,获得积分10
2分钟前
奋斗的听露完成签到,获得积分10
2分钟前
霸气的似狮完成签到,获得积分10
2分钟前
听话的秋白完成签到,获得积分10
2分钟前
Hello的应助被YYY采纳,获得10
3分钟前
hupo完成签到,获得积分10
3分钟前
含蓄的雪冥完成签到,获得积分10
3分钟前
3分钟前
高高的仇血完成签到,获得积分10
3分钟前
朴实傲白完成签到 ,获得积分10
3分钟前
3分钟前
欢呼的兰完成签到,获得积分10
3分钟前
4分钟前
MT发布了新的文献求助10
4分钟前
soleil关注了科研通微信公众号
4分钟前
贪玩醉薇完成签到,获得积分10
4分钟前
4分钟前
leoo完成签到,获得积分10
4分钟前
腿腿完成签到,获得积分10
4分钟前
欢呼的馒头完成签到,获得积分10
4分钟前
tigger完成签到 ,获得积分10
5分钟前
zilicai的应助被冷阳采纳,获得10
5分钟前
5分钟前
如意大神完成签到,获得积分10
5分钟前
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179920
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808354
捐赠科研通 7775701
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918